Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Brucella Abortus Vaccine Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 DNA Vaccines
      • 1.3.3 Subunit Vaccines
      • 1.3.4 Vector Vaccines
      • 1.3.5 B. Abortus Recombinant Mutants
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Brucella Abortus Vaccine Market Share by Application (2019-2025)
      • 1.4.2 Cattles
      • 1.4.3 Sheep
      • 1.4.4 Pigs
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Brucella Abortus Vaccine Market Size
      • 2.1.1 Global Brucella Abortus Vaccine Revenue 2014-2025
      • 2.1.2 Global Brucella Abortus Vaccine Sales 2014-2025
    • 2.2 Brucella Abortus Vaccine Growth Rate by Regions
      • 2.2.1 Global Brucella Abortus Vaccine Sales by Regions 2014-2019
      • 2.2.2 Global Brucella Abortus Vaccine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Brucella Abortus Vaccine Sales by Manufacturers
      • 3.1.1 Brucella Abortus Vaccine Sales by Manufacturers 2014-2019
      • 3.1.2 Brucella Abortus Vaccine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Brucella Abortus Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Brucella Abortus Vaccine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Brucella Abortus Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Brucella Abortus Vaccine Price by Manufacturers
    • 3.4 Key Manufacturers Brucella Abortus Vaccine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Brucella Abortus Vaccine Market
    • 3.6 Key Manufacturers Brucella Abortus Vaccine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 DNA Vaccines Sales and Revenue (2014-2019)
      • 4.1.2 Subunit Vaccines Sales and Revenue (2014-2019)
      • 4.1.3 Vector Vaccines Sales and Revenue (2014-2019)
      • 4.1.4 B. Abortus Recombinant Mutants Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Brucella Abortus Vaccine Sales Market Share by Type
    • 4.3 Global Brucella Abortus Vaccine Revenue Market Share by Type
    • 4.4 Brucella Abortus Vaccine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Brucella Abortus Vaccine Sales by Application

    6 United States

    • 6.1 United States Brucella Abortus Vaccine Breakdown Data by Company
    • 6.2 United States Brucella Abortus Vaccine Breakdown Data by Type
    • 6.3 United States Brucella Abortus Vaccine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Brucella Abortus Vaccine Breakdown Data by Company
    • 7.2 European Union Brucella Abortus Vaccine Breakdown Data by Type
    • 7.3 European Union Brucella Abortus Vaccine Breakdown Data by Application

    8 China

    • 8.1 China Brucella Abortus Vaccine Breakdown Data by Company
    • 8.2 China Brucella Abortus Vaccine Breakdown Data by Type
    • 8.3 China Brucella Abortus Vaccine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Brucella Abortus Vaccine Breakdown Data by Company
    • 9.2 Rest of World Brucella Abortus Vaccine Breakdown Data by Type
    • 9.3 Rest of World Brucella Abortus Vaccine Breakdown Data by Application
    • 9.4 Rest of World Brucella Abortus Vaccine Breakdown Data by Countries
      • 9.4.1 Rest of World Brucella Abortus Vaccine Sales by Countries
      • 9.4.2 Rest of World Brucella Abortus Vaccine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Zoetis
      • 10.1.1 Zoetis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.1.4 Brucella Abortus Vaccine Product Introduction
      • 10.1.5 Zoetis Recent Development
    • 10.2 CEVA
      • 10.2.1 CEVA Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.2.4 Brucella Abortus Vaccine Product Introduction
      • 10.2.5 CEVA Recent Development
    • 10.3 Merck Animal Health
      • 10.3.1 Merck Animal Health Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.3.4 Brucella Abortus Vaccine Product Introduction
      • 10.3.5 Merck Animal Health Recent Development
    • 10.4 Biovet
      • 10.4.1 Biovet Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.4.4 Brucella Abortus Vaccine Product Introduction
      • 10.4.5 Biovet Recent Development
    • 10.5 CAVAC
      • 10.5.1 CAVAC Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.5.4 Brucella Abortus Vaccine Product Introduction
      • 10.5.5 CAVAC Recent Development
    • 10.6 JOVAC
      • 10.6.1 JOVAC Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.6.4 Brucella Abortus Vaccine Product Introduction
      • 10.6.5 JOVAC Recent Development
    • 10.7 Merial
      • 10.7.1 Merial Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.7.4 Brucella Abortus Vaccine Product Introduction
      • 10.7.5 Merial Recent Development
    • 10.8 Colorado Serum Company
      • 10.8.1 Colorado Serum Company Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.8.4 Brucella Abortus Vaccine Product Introduction
      • 10.8.5 Colorado Serum Company Recent Development
    • 10.9 VECOL
      • 10.9.1 VECOL Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.9.4 Brucella Abortus Vaccine Product Introduction
      • 10.9.5 VECOL Recent Development
    • 10.10 Tecnovax
      • 10.10.1 Tecnovax Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Brucella Abortus Vaccine
      • 10.10.4 Brucella Abortus Vaccine Product Introduction
      • 10.10.5 Tecnovax Recent Development
    • 10.11 Indian Immunologicals
    • 10.12 Vetal
    • 10.13 Dollvet
    • 10.14 Centro Diagnostico Veterinario
    • 10.15 Onderstepoort Biological Products
    • 10.16 Institute of Animal Health and Veterinary Biologicals
    • 10.17 Biogenesis Bago
    • 10.18 Instituto Rosenbusch
    • 10.19 SYVA Laboratorios
    • 10.20 CZ Veterinaria
    • 10.21 Hester Biosciences
    • 10.22 Qilu Animal Health

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Brucella Abortus Vaccine Sales Channels
      • 11.2.2 Brucella Abortus Vaccine Distributors
    • 11.3 Brucella Abortus Vaccine Customers

    12 Market Forecast

    • 12.1 Global Brucella Abortus Vaccine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Brucella Abortus Vaccine Sales Forecast by Type
    • 12.3 Global Brucella Abortus Vaccine Sales Forecast by Application
    • 12.4 Brucella Abortus Vaccine Forecast by Regions
      • 12.4.1 Global Brucella Abortus Vaccine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Brucella Abortus Vaccine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Brucella Abortus Vaccine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Brucella Abortus Vaccine.

      This report studies the global market size of Brucella Abortus Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Brucella Abortus Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Zoetis
      CEVA
      Merck Animal Health
      Biovet
      CAVAC
      JOVAC
      Merial
      Colorado Serum Company
      VECOL
      Tecnovax
      Indian Immunologicals
      Vetal
      Dollvet
      Centro Diagnostico Veterinario
      Onderstepoort Biological Products
      Institute of Animal Health and Veterinary Biologicals
      Biogenesis Bago
      Instituto Rosenbusch
      SYVA Laboratorios
      CZ Veterinaria
      Hester Biosciences
      Qilu Animal Health

      Market Segment by Product Type
      DNA Vaccines
      Subunit Vaccines
      Vector Vaccines
      B. Abortus Recombinant Mutants
      Others

      Market Segment by Application
      Cattles
      Sheep
      Pigs
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Brucella Abortus Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Brucella Abortus Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Brucella Abortus Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now